Apoptosis induced by B-cell receptor (BCR) signaling is critical for antigen-driven selection, a process critical to tolerance and immunity. Here, we examined the roles of microRNAs (miRNAs) in BCR signaling-induced apoptosis using the widely applied WEHI-231 model. Comparison of miRNA levels in BCR-stimulated and -unstimulated cells revealed that 39 miRNAs were differentially expressed upon stimulation of the BCR. Importantly, stimulation in the presence of anti-CD40 antibodies, which rescues cells from BCR-induced apoptosis, prevented most changes in miRNA expression. Ectopic expression of mir-150 and mir-181a1b1, miRNAs that were upregulated upon BCR stimulation, resulted in inhibition of cell growth. Finally, we showed that ectopic expression of mir-150, mir-181a1b1 and mir-17B92 sensitized cells to anti-IgM stimulation-induced growth inhibition.
INTRODUCTION
Signaling through the B-cell receptor (BCR) is critical for the development and function of B cells. BCR-mediated signaling may result in different biological outcomes depending on the strength and duration of the trigger, the B-cell differentiation stage, and costimulatory signals. 1 Immature, germinal center (GC) and activated B cells undergo growth arrest and subsequent apoptosis upon BCR triggering, whereas mature B cells proliferate. 2, 3 BCR-induced apoptosis prevents the outgrowth of autoreactive B cells and is therefore critical for B cell-mediated tolerance.
MicroRNAs (miRNAs) are B22 --nucleotide regulatory RNAs that function by targeting messenger RNAs for degradation or translational inhibition. These non-coding RNAs have important roles in regulation, development and function of immune cells. 4 This was first shown in hematopoietic stem cells; overexpression of mir-181a-1 in these cells resulted in an increased number of B-lineage cells. 5 More recent data indicate that miR-181a is also involved in sensitization of T-cell receptor signaling. 6 Gain of miR-150 function in early B-cell progenitors results in a block in B-cell development, whereas loss of miR-150 function results in expansion of B1 cells and increased humoral immune responses. 7, 8 Moreover, high levels of expression of miR-155 in GC B cells is important for the GC response. 9 ,10 Interestingly, miR-155 is upregulated and miR-150 is downregulated upon BCR stimulation of purified murine spleen B cells. 7, 9 Finally, it was shown that Dicer-deficient mature B cells produce high titers of autoreactive antibodies. 11 These studies clearly indicate that miRNAs are regulated upon BCR signaling and direct B-cell development and function.
Here, we investigated the regulation of miRNA expression upon BCR stimulation in WEHI-231 cells. This model has been used extensively to investigate BCR stimulation-induced apoptosis and its role in B cell-mediated tolerance. 12 BCR stimulation of WEHI-231 cells using anti-IgM induces growth arrest and apoptosis; co-stimulation with CD40L or anti-CD40 antibodies prevents apoptosis. 13 Comparison of miRNA levels in BCRstimulated and -unstimulated cells using microarrays identified miRNAs that were differentially expressed upon stimulation of BCR signaling. The functional consequences of ectopic expression of these miRNAs were evaluated and identified miRNAs that affect cell growth and/or sensitization to BCR stimulation. Table 1 ). In all, 30 of these were consistently differentially expressed when anti-IgM stimulation was compared with anti-IgM þ anti-CD40 co-stimulation or anti-CD40 alone (Figure 1c) . Two miRNAs differed significantly in cells stimulated with anti-IgM þ anti-CD40 and one in cells treated with anti-CD40 alone compared with untreated cells.
RESULTS

BCR stimulation induces widespread changes in
Among the miRNAs differentially regulated upon anti-IgM stimulation compared with untreated, 10 miRNAs were upregulated and 29 were downregulated. Five members of the miR-17B92 cluster were downregulated, whereas miR-92a levels did not change. Four members of the homologous miR-106aB363 and miR-106bB25 clusters were also downregulated. MiR-34a was downregulated upon BCR stimulation and upregulated upon anti-CD40 stimulation; the opposite effect was observed for miR-150.
Differential expression was confirmed by quantitative RT--PCR (qRT--PCR) for 9 of the 10 selected miRNAs (Figure 1d ). For miR-1224, qRT-PCR could not confirm the increased levels upon antiIgM stimulation. Because of its known role in modulating TCR signaling, 6 we also analyzed the levels of miR-181a and miR-181b and found 2-fold and 1.6-fold increases in expression levels upon BCR stimulation, respectively. These levels were slightly higher than values determined by microarray analysis (1.2-fold for both). Several miRNAs that are regulated upon BCR stimulation affect cell growth As BCR stimulation of WEHI-231 cells results in growth arrest followed by apoptosis, we examined whether ectopic expression of the identified miRNAs would be sufficient to influence cell growth using a GFP competition assay. If the observed miRNA changes are important to cell growth, then ectopic expression of the miRNAs upregulated in our comparison analysis should negatively influence cell growth; vice versa, ectopic expression of miRNAs with reduced levels may prevent apoptosis or even enhance cell growth. Six miRNAs were selected for retroviral overexpression based on significant differential expression upon BCR stimulation compared with untreated cells and compared with BCR stimulation with CD40 co-stimulation as well as reported functions in immune homeostasis, cell growth or apoptosis. Four miRNAs with increased levels upon BCR stimulation were selected (miR-150, miR-181a1b1, miR-342-3p and miR-680) and two with decreased levels (miR-17B92 and miR-34a). After infection, cells were sorted based on GFP, and miRNA overexpression was confirmed by qRT--PCR (Figure 2a ). Overexpression varied from a few fold (miR-17B92 members) up to 1381-fold (miR-342-3p).
To determine the effect of miRNA overexpression on cell growth, we mixed wild-type and miRNA virus-transduced WEHI-231 cells and monitored the change in the percentage of infected cells (GFP-positive cells) over time. A reduction in the percentage of GFP-positive cells indicates that ectopic miRNA expression has negative effects on cell growth, whereas an increase suggests a positive effect on cell growth. Ectopic expression of miR-34a, which decreased upon BCR stimulation, showed the strongest negative effect on cell growth with 460% reduction of GFP-positive cells 3 days after the initiation of competition assay. Significant reductions in percent of GFP-positive cells were also observed when either mir-150 or mir-181a1b1, miRNAs upregulated upon BCR stimulation, was ectopically expressed in WEHI-231 cells (Figure 2b and Supplementary Figure 2) . For miR-150 and miR-181a1b1, a 50% reduction in GFP-positive cells took 7 days. In contrast, no significant differences in GFP percentage were observed over time for the empty vector control or when miR-680, miR-342-3p or miR-17B92 was overexpressed. Thus, the increased levels of miR-150 and miR181a1b1 upon BCR stimulation induced growth arrest were consistent with the observed negative effects of ectopic expression of these miRs on WEHI-231 cell growth. In contrast, ectopic expression of miR-34a resulted in growth inhibition even though this miRNA was downregulated upon BCR stimulation. 
DISCUSSION
In this study, we investigated the role of miRNAs in BCR-induced growth arrest and apoptosis using the WEHI-231 model. We showed that 39 miRNA were upregulated or downregulated upon BCR stimulation. Co-stimulation via CD40, which prevents apoptosis, also prevented the vast majority of these changes in miRNA expression. On the other hand, anti-CD40 stimulation alone only induced the expression of one miRNA. Together, these results suggest that most of the changes in miRNA expression observed upon BCR stimulation alone are downstream of a pathway that is blocked by CD40 co-stimulation.
To investigate the functional consequences of the miRNAs that are regulated upon BCR stimulation, we ectopically expressed several miRNAs. Using a competition assay we found that ectopic expression of miR-34a, miR-150 or miR-181a1b1 negatively affected the growth of WEHI-231 cells. The growth inhibitory effect upon overexpression of these miRNAs was at least in part due to cell intrinsic factors as paracrine factors would affect both the GFP þ and GFPÀ cells both present in the same culture flask. Moreover, sorted GFP þ cells grew at slower rates than the empty vector control (data not shown). The negative effect on cell growth was expected for miR-150 and miR-181a1b1 as these miRNAs were upregulated upon BCR stimulation. These miRNAs may regulate expression of proteins that affect growth arrest and/ or apoptosis. Ectopic expression of miR-150 in vivo impairs early B-cell development by regulation of c-Myb. 7, 8 The anti-apoptotic genes Bcl-2 and Mcl-1 are targets of miR-181. 14 --16 Whether these and/or other targets are relevant to the observed phenotype in WEHI-231 cells remains to be determined. Overexpression of miR-34a showed the strongest negative effect on cell growth. However, this miRNA was downregulated upon 24 h BCR stimulation suggesting that miR-34a does not directly function in BCR-induced growth arrest and/or apoptosis. Nevertheless, the effects of miR-34a on WEHI-231 growth are consistent with reports showing that ectopic expression of miR-34a inhibits growth of cancer cells. 17 MiR-34a is also known to be regulated by p53. Upon anti-IgM stimulation of WEHI-231 cells p53 is initially rapidly induced, but levels strongly decline after 4 h BCR stimulation to baseline or lower. 18 This suggests that the lowered miR-34a 24 h after BCR stimulation may be caused by the lowered p53 levels. Thus, we demonstrated that some of the BCR-regulated miRNAs are directly involved in the regulation of BCR-induced growth arrest and/or apoptosis.
Next, we tested whether the BCR-regulated miRNAs may play roles in sensitizing the BCR signaling. Expression of miR-181a1b1, miR-150 and miR-17B92 each sensitized WEHI-231 cells to BCR stimulation-induced growth arrest and/or apoptosis. These results, together with the observation that miR-150 and miR-181a1b1 inhibit growth in the long-term GFP competition assay (Figure 2b ), suggest that miR-150 and miR-181a1b1 contribute to BCR-induced growth inhibition and/or apoptosis at least in part by potentiating BCR signaling. The finding that overexpression of the miR-17B92 cluster resulted in sensitization to BCR-induced apoptosis seems contradictory in the light of the overwhelming literature evidence showing that overexpression of miR-17B92 cluster attenuates apoptosis. 19, 20 A possible explanation for the observed effect is that this is due to the regulation of WEHI-231 specific miR-17B92 targets. MiR-34a expression did not result in sensitization despite its strong effects in the long-term GFP competition assay without stimulation, supporting our hypothesis that this miRNA does not have a direct role in BCR-induced growth arrest and/or apoptosis in WEHI-231 cells. The effects of miR-181a1b1 expression on the sensitivity to BCR stimulation are consistent with data from a previous study showing that miR-181a augments TCR signaling strength by dampening the expression of multiple phosphatases. 6 These phosphatases are expressed in B cells and may be regulated by miR-181a1b1. 21, 22 During development B-cells become IgM þ at the Hardy fraction E stage (immature B cells) and lose IgM expression once they have progressed via the T1 --T3 stages to the follicular B-cell stage (mature naïve B cells). During this differentiation B cells with autoreactive BCRs need to be deleted. MiR-150 and miR-181a and -b expression levels peak during differentiation from the Hardy fraction E stage to follicular B-cell stage (miR-150 at T2/T3 and miR-181a and B at Hardy fraction E). 23 This suggests that, during B-cell differentiation, the levels of these miRNAs may be up-regulated to sensitize B cells to BCR-induced growth arrest and apoptosis to specifically delete B cells with autoreactive BCRs.
In conclusion, we have identified miRNAs that are upregulated or downregulated upon BCR-induced growth arrest and apoptosis. Through functional analyses, we demonstrated that among these miRNAs, miR-150 and miR-181a1b1 sensitize WEHI-231 cells to apoptosis induced by BCR stimulation. BCR-induced apoptosis prevents the outgrowth of autoreactive B cells; dysregulation of BCR signaling may result in autoimmune diseases and contribute to lymphomagenesis. Therefore, it will be very interesting to determine whether miR-150 and/or miR-181a1b1 are involved in these diseases.
MATERIALS AND METHODS
Cell culture and stimulations WEHI-231 cells (ATCC, Rockville, MD, USA) were cultured in RPMI-1640 with 10% fetal bovine serum, 50 mm 2-mercaptoethanol, 100 U ml --1 penicillin, 0.1 mg ml --1 streptomycin, and 2 mM ultraglutamine (Cambrex Biosciences, Walkersville, MD, USA). Cells were seeded at 1 Â 10 5 cells ml --1 and rested for 1 h before stimulation with 0.1 mg ml --1 anti-IgM (goat-anti-mouse F(ab') 2 fragments, Jackson ImmunoResearch, Westgrove, PA, USA) and/or 0.5 mg ml --1 anti-CD40 antibodies (clone 1C10, SouthernBiotech, Birmingham, AL, USA). For the miRNA microarray profiling analyses, two independent large-scale stimulations were carried out; part of each sample was used for apoptosis analysis and part was used for RNA isolation.
RNA isolation and miRNA expression profiling RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, USA). miRNA microarray analyses were performed with 100 ng total RNA using the Agilent Oligo Microarray Kit according to the manufacturer's protocol (G4472A, Agilent, Santa Clara, CA, USA). Microarray data was analyzed using Genespring software (version GX 10.0, Agilent) and normalized using percentile shift (75th percentile). miRNAs that were flagged as present in at least one out of eight samples were selected, resulting in 125 entities. Oneway ANOVA with appropriate multiple testing correction (Benjamini --Hochberg, adjusted P value o0.05) was applied to identify differentially expressed miRNAs. Finally, a cutoff of X2-fold difference in expression level was applied. For validation experiments, qRT-PCR was performed using miRNA qPCR assays and 5 ng total RNA as input (Applied Biosystems, Foster City, CA, USA). All reactions were run in triplicate and mean cycle threshold (C t ) values for all miRNAs were quantified with the sequence detection system software (SDS, version 2.1, Applied Biosystems). Expression levels were normalized to levels of snoRNA429.
miRNA overexpression miRNAs were cloned as previously described. 5 Briefly, primers with 5 0 Xho1 and 3 0 EcoR1 restriction sites were designed to amplify the miRNA precursor and flanking sequence (Supplementary Table 1 ). miRNA genes were amplified from DNA of C57BL/6 male mice and cloned into the retroviral vector MXW-PGK-IRES-GFP. 24 For virus production, 293T cells were CaPO 4 transfected with a retroviral expression construct and pCL-Eco and virus were harvested after 2 days. WEHI-231 cells were infected by 2 h spinning at 2000 rpm with a final polybrene concentration of 4 mg ml --1 . Infected cells were purified by FACS sorting of GFP-positive cells. miRNA overexpression was confirmed by qRT--PCR on GFP-sorted cells as described in the previous section.
FACS analysis
Apoptosis of WEHI-231 cells after BCR stimulation was measured by annexin V staining (Annexin V-APC, BD PharMingen, San Diego, CA, USA) in combination with propidium iodide (PI) staining (Sigma, St Louis, MO, USA). After gating out cellular debris, apoptosis levels were calculated as the percentage of annexin V þ /PI À cells within the total PI À gate. For the competition assay, freshly infected cells (infection rate 25 --70%, adjusted to a maximum 50% GFP-positive cells) were analyzed for changes of percentage of GFP-positive cells three times a week. The GFP percentage determined at the first day of measurement (4 days post infection) was set to 1. For each measurement the average decline per day was calculated and used to determine whether the average decline in GFP percentage was significantly different from that observed with cells infected with empty vector (one-way ANOVA, with Dunnet's multiple comparison post test, P value o0.05). Results for miR-34a, miR-150, miR-181a1b1 and the empty vector control were repeated with independent infections to ensure that results were not due to viral integration effects. For the anti-IgMstimulated miRNA-overexpressing cell cultures, all experiments were performed in triplicate with independent infections. Within one infection, cells were either stimulated or left untreated in triplicate. After 24 h of stimulation, GFP percentages were determined. The average GFP percentage of anti-IgM-stimulated cells was divided by that of unstimulated cells. One-way ANOVA analysis with Dunnet's multiple comparison post test was performed to determine which miRNA overexpressing cell cultures showed significant decreases in GFP percentages as compared with the empty vector control (P value o0.05). Data from all assays were
